CVS Settles Insulin Pen Scandal for $38M
Update: 2025-12-02
Description
CVS Health to Pay $38 Million to Settle Insulin Pen Billing Dispute: The U.S. Attorney in Manhattan announced a settlement where CVS Health agreed to pay nearly $38 million to resolve claims of over-dispensing insulin pens and improperly billing government healthcare programs. The company is accused of dispensing more pens than prescribed, underreporting actual usage, and instructing staff to report maximum days-of-supply for rapid claim approval. The settlement includes $24.45 million for the federal government and funds for various U.S. states.
The Daily News Now! - Every city. Every story. AI Powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
